SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 102.20   2.93 (+2.95%) Volume: 382.72k 11:28 AM EDT 19-Sep-2019
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities112/12/2018
8-K/AAmendment to a previously filed 8-K312/06/2018
SC 13D/AAmendment to a SC 13D filing1011/13/2018
8-KReport of unscheduled material events or corporate changes.211/13/2018
10-QQuarterly report with a continuing view of a company's financial position4811/08/2018
8-KReport of unscheduled material events or corporate changes.1411/08/2018
4Statement of changes in beneficial ownership of securities110/25/2018
4Statement of changes in beneficial ownership of securities110/15/2018
4Statement of changes in beneficial ownership of securities110/12/2018
8-KReport of unscheduled material events or corporate changes.310/10/2018
4Statement of changes in beneficial ownership of securities110/09/2018
8-KReport of unscheduled material events or corporate changes.310/09/2018
4Statement of changes in beneficial ownership of securities110/02/2018
4Statement of changes in beneficial ownership of securities110/02/2018
4Statement of changes in beneficial ownership of securities109/27/2018
123456789101112131415